Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Lexicon Pharmaceuticals (NASDAQ:LXRX) shares plummeted after the company received a written notice from Sanofi (NASDAQ:SNY) terminating the agreement for the development and commercialization of the company's Diabetes drug candidate Sotagliflozin.
Lexicon Pharmaceuticals shares were trading were trading down 47.45% at $2.99 in Monday’s pre-market session. The stock has a 52-week high of $12.95 and a 52-week low of $4.25.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Sanofi shares were trading up 2.34% at $43.35 in Monday’s pre-market session. The stock has a 52-week high of $45.62 and a 52-week low of $40.19.
Related Links:
Sanofi, Google Partner On Health Care-Focused Virtual Innovation Lab
Valeritas Insulin Device For Diabetics Accepted Under Managed Formulary
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.